BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18359230)

  • 1. A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues.
    Caballero J; Fernández M; González-Nilo FD
    Bioorg Med Chem; 2008 May; 16(9):5103-8. PubMed ID: 18359230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds.
    Bookser BC; Ugarkar BG; Matelich MC; Lemus RH; Allan M; Tsuchiya M; Nakane M; Nagahisa A; Wiesner JB; Erion MD
    J Med Chem; 2005 Dec; 48(24):7808-20. PubMed ID: 16302820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds.
    Caballero J
    J Mol Graph Model; 2010 Nov; 29(3):363-71. PubMed ID: 20863730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TOPS-MODE approach to predict adenosine kinase inhibition.
    González MP; Moldes del Carmen Terán M
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3077-9. PubMed ID: 15149648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.
    Srikanth K; Debnath B; Jha T
    Bioorg Med Chem Lett; 2002 Mar; 12(6):899-902. PubMed ID: 11958989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.
    Basu A; Jasu K; Jayaprakash V; Mishra N; Ojha P; Bhattacharya S
    Eur J Med Chem; 2009 Jun; 44(6):2400-7. PubMed ID: 19000644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.
    Perner RJ; Lee CH; Jiang M; Gu YG; Didomenico S; Bayburt EK; Alexander KM; Kohlhaas KL; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2803-7. PubMed ID: 15911258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.
    Bookser BC; Matelich MC; Ollis K; Ugarkar BG
    J Med Chem; 2005 May; 48(9):3389-99. PubMed ID: 15857145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
    Chamberlain SD; Redman AM; Wilson JW; Deanda F; Shotwell JB; Gerding R; Lei H; Yang B; Stevens KL; Hassell AM; Shewchuk LM; Leesnitzer MA; Smith JL; Sabbatini P; Atkins C; Groy A; Rowand JL; Kumar R; Mook RA; Moorthy G; Patnaik S
    Bioorg Med Chem Lett; 2009 Jan; 19(2):360-4. PubMed ID: 19071018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives.
    Caballero J; Fernández M; Saavedra M; González-Nilo FD
    Bioorg Med Chem; 2008 Jan; 16(2):810-21. PubMed ID: 17964795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
    Caballero J; Fernández M; González-Nilo FD
    Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles.
    Fernández M; Tundidor-Camba A; Caballero J
    J Chem Inf Model; 2005; 45(6):1884-95. PubMed ID: 16309296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
    Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
    ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.
    Perner RJ; Gu YG; Lee CH; Bayburt EK; McKie J; Alexander KM; Kohlhaas KL; Wismer CT; Mikusa J; Jarvis MF; Kowaluk EA; Bhagwat SS
    J Med Chem; 2003 Nov; 46(24):5249-57. PubMed ID: 14613327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.
    Matulenko MA; Paight ES; Frey RR; Gomtsyan A; DiDomenico S; Jiang M; Lee CH; Stewart AO; Yu H; Kohlhaas KL; Alexander KM; McGaraughty S; Mikusa J; Marsh KC; Muchmore SW; Jakob CL; Kowaluk EA; Jarvis MF; Bhagwat SS
    Bioorg Med Chem; 2007 Feb; 15(4):1586-605. PubMed ID: 17197188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y; Gao W; Li F; Wang J; Zhang J; Yang Y; Zhang S; Yang L
    Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors.
    Liu Y; Fang J; Cai H; Xiao F; Ding K; Hu Y
    Bioorg Med Chem; 2012 Sep; 20(18):5473-82. PubMed ID: 22898255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of novel 5-substituted pyrrolo[2,3-d]pyrimidine analogues as pp60(c-Src) tyrosine kinase inhibitors.
    Olgen S; Isgör YG; Coban T
    Arch Pharm (Weinheim); 2008 Feb; 341(2):113-20. PubMed ID: 18214841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.
    Caldwell JJ; Davies TG; Donald A; McHardy T; Rowlands MG; Aherne GW; Hunter LK; Taylor K; Ruddle R; Raynaud FI; Verdonk M; Workman P; Garrett MD; Collins I
    J Med Chem; 2008 Apr; 51(7):2147-57. PubMed ID: 18345609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.